Cancer Targeted Technology

Cancer Targeted Technology is designing and patenting small molecule drugs for cancer with unique diagnostic imaging and therapeutic properties.

diagnostic

CTT1057
PET Imagine Agent for
Prostate Cancer

therapeutic

CTT1403
Radiotherapeutic for
Prostate Cancer

therapeutic

CTT2274
Chemotherapeutic for
Prostate Cancer

Latest News

June 29, 2021

Cancer Targeted Technology Receives Milestone Payment for Development of Diagnostic PET Imaging Agent for Prostate Cancer

August 7, 2020

NIH grants $1.44M to Cancer Targeted Technology to Support the Ongoing Prostate Cancer Clinical Trial of a Promising New Radiotherapeutic, CTT1403

November 6, 2018

Cancer Targeted Technology Files Investigational New Drug Application for CTT1403, a Novel Radiotherapeutic Drug for Prostate Cancer